SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

07 Nov 2023 Evaluate
Net sales declined -7.74%  to  Rs. 664.33 million from Rs. 720.03 millions.Net profit of the cmpany stood at Rs. 67.82 millions for the quarter ended September 2023 a decline of -34.44% from Rs. 103.45 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 132.13 millions from 179.59 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 664.33 720.03 -7.74 1467.78 1225.31 19.79 2540.00 2193.51 15.80
Other Income 12.20 21.77 -43.96 20.79 34.11 -39.05 53.23 46.57 14.30
PBIDT 132.13 179.59 -26.43 254.37 283.91 -10.40 602.09 652.26 -7.69
Interest 14.75 17.43 -15.38 24.17 30.12 -19.75 64.97 24.68 163.25
PBDT 117.38 162.16 -27.61 230.20 253.79 -9.30 537.12 627.58 -14.41
Depreciation 25.78 23.37 10.31 51.26 47.30 8.37 97.88 95.02 3.01
PBT 91.60 138.79 -34.00 178.94 206.49 -13.34 439.24 532.56 -17.52
TAX 23.78 35.34 -32.71 46.41 52.99 -12.42 115.82 137.39 -15.70
Deferred Tax -1.06 0.10 -1160.00 -2.10 -2.42 -13.22 8.55 -5.14 -266.34
PAT 67.82 103.45 -34.44 132.53 153.50 -13.66 323.42 395.17 -18.16
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 19.89 24.94 -20.26 17.33 23.17 -25.21 23.70 29.74 -20.28

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×